SPO Global Inc. (SPOM: OTC Pink Current) | Sales Growth off the Scale for First 2 Months of Q2 2017 Compared to Same Period 2016

OTC

Sales Growth off the Scale for First 2 Months of Q2 2017 Compared to Same Period 2016

Jun 08, 2017

OTC Disclosure News Service

Woburn, MA

 

 

Sales Growth off the Scale for First 2 Months of Q2 2017 Compared to Same Period 2016.

 

 

To All Shareholders:  Woburn / 08 June, 2017.

 

We are pleased to inform all our shareholders that in the first 2 months (April May) of Q2 2017 we have already invoiced over $106,000 of business with major clients in the US UK.  Compared to sales for April May 2016 of $7,500 this represents an increase of more than 14 times, year on year.

 

Our technical team is at full capacity and working hard to deliver projects and we are recruiting more staff, to handle the increasing volume of business that the company is receiving.  Our next round of recruitment in the second half of 2017, will be to increase our sales team in order to ensure we keep our sales growth and pipeline strong as we move towards 2018.

 

The future looks bright and the opportunity to realize substantial value for all our staff and shareholders is our main focus.

 

We are very pleased you can be a part of our future success.

 

Owen Dukes

 

 

This shareholder letter contains forward-looking statements that involve substantial uncertainties and risks. These forward-looking statements are based upon our current expectations, estimates and projections about our business and our industry, and that reflect our beliefs and assumptions based upon information available to us at the date of this release. We caution readers that forward looking statements are predictions based on our current expectations about future events. These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and assumptions that are difficult to predict. Our actual results, performance or achievements could differ materially from those expressed or implied by the forward-looking statements as a result of a number of factors, including but not limited to, expectations regarding the successful expansion of our product base, profitability, market acceptance of our products and new product applications, timing of new product launches, product performance, size of prospective markets, marketing strategies, success of our restructured operations and plans, our ability to generate fees or raise apital to support our business operations and plan, the sufficiency and availability of working capital, changes in economic conditions generally and in more specifically, the introduction of competing products, changes in our operating strategy or development plans, patent protection for our products and technologies, changes in economic conditions generally and in more specifically, in the markets we operate, changes in technology, legislative or regulatory changes that affect us. We undertake no obligation to revise or update any forward-looking statement for any reason. 

This release includes additional documents. Select the link(s) below to view.

SPO Global  Shareholder Ltter 8th June.pdf

Copyright © 2017 OTC Markets. All Rights Reserved

The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.

Leave a Reply